Tomer has over 20 years experience in Technology Entrepreneurship both as founder, executive, venture capitalist, and angel investor. Tomer has founded 13 companies, including 2 major exits, invested in over 50 companies with 3 M&A exits and 2 IPOs, and has raised over $250M for his companies. In addition to TGV, Tomer is also Founder & CEO of 20|30 Holdings, a growth-stage integrated group of Blockchain companies, and is also co-founder of the Pillar Project and sits on the Pillar Project Foundation board.
Keynote
Venture Capital
Technology, Software
Jim Pettit
Aben resources
Jim Pettit has been President and Chief Executive Officer and a Director of Aben Resources Ltd. since November 2002. Mr. Pettit is currently serving on the board of directors of five publicly traded venture companies and offers over 25 years of experience within the industry specializing in finance, corporate governance, executive management and compliance. Mr. Pettit was previously Chairman and C.E.O. of Bayfield Ventures Corp. which was bought by New Gold Inc. in January 2015. Mr. Pettit specializes in early stage exploration projects that are located in secure jurisdictions and have high-grade gold potential.
Keynote
Private Company
Commodities, Precious Metals
Masha Drokova
Day One Ventures
Masha Drokova is the Founder of Day One Ventures, an early-stage venture fund leading startups' communications. Day One Ventures has invested in the likes of Superhuman, FutureFamily, DigitalGenius, Domuso, Atoms, CatalogDNA, Nebia and others. In 2019 Masha was recognized in Forbes 30 Under 30.
Masha entered the tech industry at Russian Quantum Center where she worked with Nobel Prize winners and prominent quantum physicists. Later Masha joined Runa Capital as PR Director and then she became Vice President of Communications at Acronis. Afterwards Masha launched her PR Studio which worked with companies like WeWork, Houzz, HotelTonight, Gett, and Toptal.
Keynote
Venture Capital
Technology
Ryan Beal
Dyve Biosciences
Ryan Beal, M.D. is a serial entrepreneur focused on biopharma drug delivery innovation. He is recognized for his ability to leverage his scientific, R&D, and clinical acumen with a creative strategic and commercial mind. He has led the launch of medical products with collective annual peak sales over $50 billion and been involved with the founding of multiple healthcare companies. Prior to his entrepreneurial endeavors, Dr. Beal spent 7 years with McKinsey & Company where he was a leader in their Pharmaceutical Practice. He earned an M.D. with honors from the University of Pennsylvania School of Medicine and a BA with honors in Biophysical Chemistry from Dartmouth College
Keynote
Private Company
Healthcare, Medtech
Ron F. Hochstein
Lundin Gold
Ron has a wealth of experience in the mining industry and has worked for the Lundin family directly and as a consultant for over 20 years. Prior to becoming President and CEO of Lundin Gold, Mr. Hochstein served as President and CEO of Denison Mines Corp. (TSX, NYSE MKT), a uranium exploration and development company for seven years, having joined a predecessor company to Denison in 1999. Earlier in his career, Mr. Hochstein was a Project Manager with Simons Mining Group and worked at Noranda Minerals as a metallurgical engineer. Mr. Hochstein has a B.Sc. in metallurgical engineering and an MBA. Mr. Hochstein became President and Chief Executive Officer in 2014 and was instrumental in the acquisition of Fruta del Norte.
Keynote
Private Company
Precious Metals, Commodities
Sam Scherwitz
Genoptic
Genoptic LED Inc. was founded by Samson Scherwitz. Mr. Scherwitz has been an industry leader in lighting and display manufacturing and distribution throughout Canada and abroad for over 20 years and is currently the CEO of LED Sign Supply Inc. and Evergreen LED Inc. and a Founding Director of Green Sky Labs Inc.
Keynote
Private Company
Technology
Martin G. Tobias
Upgrade Labs
Martin Tobias is a serial entrepreneur, investor and philanthropist. He has invested in over 70 startups and been early in many large markets including software (Microsoft), streaming media, renewable fuels and now the intersection of health, fitness and technology. Martin has reversed his cellular age by 20 years over the last two years with less than an hour in his next generation gym a week and is passionate about scaling this to everyone
Keynote
Private Company
Wellness
Jay Park
Recon Africa
Jay Park QC is Chief Executive Officer of ReconAfrica. Mr. Park is an energy lawyer with over 35 years of experience advising on oil and gas projects in over 50 countries, with a particular focus on Africa. Mr. Park has served as a director or officer or both of a number of oil and gas companies with operations in Africa, including as chairman and director of Voyageur Oil and Gas Corporation, which explored the Borj El Khadra Sud block in Tunisia, farmed out to Anadarko, and as a director of Caracal Energy Inc. with oil producing assets in the Doba basin of Chad, acquired by Glencore International.
Keynote
Private Company
Commodities, Oil & Gas
John Sanderson
XO Stem
Dr. Sanderson, along with XOStem co-founder Dr. Jonathan Lakey, a professor at the University of California, have been collaborating for the past decade to pursue discovery and product innovations applying stem cell science with a primary target of diabetes mellitus. Dr. Sanderson is a physician-scientist and serial entrepreneur with a track record of successful products and companies, and was a Medical Director of Johnson & Johnson, the world’s largest healthcare company. He also founded Cellese Regenerative Therapeutics, a private company with global reach devoted to dermatology and aesthetics. He serves as a board member for several public companies.
Keynote
Private Company
Biotech
Corporates
Company backgrounds and useful links.
True Global Ventures
Tomer Sofinzon
True Global Ventures 4 Plus is a decentralized fund with 80 founding partners and affiliates across 30 cities. The fund is set up to invest in Series B and C revenue-generating startups that are using or just about to utilize Distributed Ledger Technologies. The fund invests across 4 main verticals which the team of 80 partners has expertise in, namely: Infrastructure and Protocols, Financial Services, Data Analytics and Artificial Intelligence, Entertainment and Media. These 4 verticals cover 14 subsegments including Real Estate, Private & Public Capital Markets, Payments, Logistics, Agriculture, Power, Healthcare, Art & Collectibles, Video Gaming and Streaming.
Keynote
Venture Capital
Technology, Software
Aben resources
Jim Pettit
Aben Resources Ltd. is a publicly traded Canadian GOLD exploration company with significant projects in BRITISH COLUMBIA and the YUKON TERRITORY.
The Company's flagship 23,000 hectares FORREST KERR GOLD PROJECT is located in the heart of a region called the GOLDEN TRIANGLE in northwestern British Columbia. This region has hosted significant past and present mineral deposits including: Pretium (Brucejack), Eskay Creek, Snip, Galore Creek, Copper Canyon, Schaft Creek, KSM, Granduc, Red Chris and more.
Aben also holds a 100% interest in the 7,411 hectares JUSTIN GOLD PROJECT located in the southeast Yukon. The Justin property is located on the Tintina Gold Belt to the immediate southeast of Golden Predator's 3 Aces gold project.
Keynote
Private Company
Commodities, Precious Metals
Day One Ventures
Masha Drokova
Day One Ventures is an early stage venture capital firm pioneering a new model in VC by spearheading public relations programs for its portfolio companies. This enables Day One to become actively involved in its portfolio companies and play a real, tangible role in helping them grow. The firm invests in hard-to-imitate tech and community-driven businesses that will fundamentally change industries, and solve some of today’s biggest challenges across business and society. Day One Ventures is focused on building the most founder-centric fund and was founded by angel investor, entrepreneur, and communications executive, Masha Drokova
Keynote
Venture Capital
Technology
Dyve Biosciences
Ryan Beal
Dyve Biosciences is an R&D focused biotech that has developed a breakthrough platform technology broadly enabling transdermal drug delivery.
Dyve has advanced clinical programs in gout and melasma that demonstrate the power and potential of the technology.
Keynote
Private Company
Healthcare, Medtech
Lundin Gold
Ron F. Hochstein
Lundin Gold is building its 100% owned Fruta del Norte Gold Project in southeast Ecuador. It is one of the world’s highest-grade and largest gold mines currently under construction with first gold expected in Q4 of this year. Reserves are 5.02 million ounces gold grading 8.74 g/t gold. Average annual production during the first 13 years is expected to exceed 310,000 ounces per year with an estimated all-in sustaining cost of US$583 per ounce. The Company’s board and management team have extensive expertise in mine construction and operations and are dedicated to advancing this project through to first gold production. The Company believes that the value created through the development of Fruta del Norte will benefit its shareholders, the Government and the citizens of Ecuador.
Keynote
Private Company
Precious Metals, Commodities
Genoptic
Sam Scherwitz
Genoptic LED Inc. is an advanced research and development company specializing in energy efficient Nano-optoelectronic technologies. The R&D team of Genoptic consists of highly experienced engineers and scientists who have successfully translated research into advanced commercial and industrial product solutions. These cutting edge technologies will provide a wide variety technological advancements in such industries including but not limited to LED lighting, digital display, solar, medical science and agriculture. The company has over 1.3 billion in current purchase contracts and will bring massive economic growth opportunities throughout the world.
Keynote
Private Company
Technology
Upgrade Labs
Martin G. Tobias
You know how people often feel frustrated that they’re not reaching their health and fitness goals, but they sense they could if they had access to the same tools and resources as the super wealthy or professional athletes? At Upgrade Labs, we combine our proprietary data platform with the technologies and secrets of those at the top of their game to help our members achieve the results they deserve. Upgrade Labs has two Signature Labs in Los Angeles and hosts the annual 1,500-person Biohacking summit. The company is building a mass market store format in Q3 which it intends to franchise worldwide. The company just raised a Series B and will pursue a Series C in Q1 of 2020.
Keynote
Private Company
Wellness
Recon Africa
Jay Park
ReconAfrica is a junior oil and gas company exploring Namibia’s Kavango Basin, a deep sedimentary basin of more than 25,000 km2, similar in size to the Eagle Ford shale play in Texas. ReconAfrica’s licence gives it a 90% interest in the entire basin. Every tested sedimentary basin of similar size and depth globally produces commercial hydrocarbons. ReconAfrica begins a three well testing program in the second half of 2019, with the objective of confirming a working hydrocarbon system in the Kavango Basin which would support both large scale conventional and non-conventional play types. ReconAfrica’s current financing offers investors the opportunity to buy into the Kavango Basin at a land value of $1.43 per acre; based on success in the current three well program, the average per acre value of similar projects in the US, Australia and Argentina is $840 per acre. By early July, ReconAfrica will be trading under the symbol RECO on Canada’s TSX Venture Exchange.
Keynote
Private Company
Commodities, Oil & Gas
XO Stem
John Sanderson
XOStem is pursuing innovations in the science of stem cells and exosomes, with target applications in Type 1 & 2 diabetes, aging, and arthritis. With a strong portfolio of successful preclinical experience, the XOStem team is testing now in primates a combined micro- and macro-encapsulated islet cell organoid (credit card-sized) subcutaneous implant for type 1 diabetes, and engineered nanosomal (exosomes) for type 2 diabetes, aging and arthritis. In contradistinction to the typical long runway to regulated medical markets, XOStem introduces first a diabetes implant for dogs & cats. Positive feedback & support has been obtained from the USFDA. XOStem has also identified multiple opportunities for early revenue including a catalog of engineered (cargo tuned) exosomes for research.
